Search results
Results from the Tech24 Deals Content Network
Like many REIT investors, Chimera (NYS: CIM) shareholders aren't exactly satisfied with what happened to their stock in 2011. Even including dividends, they're now 28% in the hole. But the past is ...
Chimera (CIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Let's take a look at Chimera Investment (NYS: CIM) today and Examine its pros and cons, and decide whether its possible upside outweighs its risks. Buy, Sell, or Hold: Chimera Investment
According to Greek mythology, [1] the Chimera, Chimaera, Chimæra, or Khimaira (/ k aɪ ˈ m ɪər ə, k ɪ-/ ky-MEER-ə, kih-; Ancient Greek: Xίμαιρα, romanized: Chímaira, lit. 'she-goat') [ 2 ] was a monstrous fire-breathing hybrid creature from Lycia , Asia Minor , composed of different animal parts.
Chimera, Chimaera, or Chimaira (Greek for "she-goat") originally referred to: Chimera (mythology) , a fire-breathing monster of ancient Lycia said to combine parts from multiple animals Mount Chimaera , a fire-spewing region of Lycia or Cilicia typically considered the inspiration for the myth
Chimera (genetics) Two-colored rose chimera. A genetic chimerism or chimera ( / kaɪˈmɪərə / ky-MEER-ə or / kɪˈmɪərə / kim-EER-ə) is a single organism composed of cells with more than one distinct genotype. In animals and human chimeras, this means an individual derived from two or more zygotes, which can include possessing blood ...
As the world's third-richest person and most celebrated investor, Warren Buffett attracts a lot of attention. Thousands try to glean what they can from his thinking processes and track his ...
Need help? Call us! 800-290-4726 Login / Join. Mail